Cargando…
Autoantibodies in post-treatment Lyme disease syndrome
Autores principales: | Alaedini, Armin, Wormser, Gary P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475069/ https://www.ncbi.nlm.nih.gov/pubmed/36119670 http://dx.doi.org/10.3389/fneur.2022.1004853 |
Ejemplares similares
-
Peptidylarginine Deiminase 2 Autoantibodies Are Linked to Less Severe Disease in Multiple Sclerosis and Post-treatment Lyme Disease
por: Kim, Yaewon, et al.
Publicado: (2022) -
Investigation of Possible Link between Interferon-α and Lyme Disease
por: Alaedini, Armin, et al.
Publicado: (2023) -
Myositis Autoantibodies in Patients with Suspected Post-Treatment Lyme Disease Syndrome
por: Sloupenska, Kristyna, et al.
Publicado: (2023) -
Autoantibodies in the Extraintestinal Manifestations of Celiac Disease
por: Yu, Xuechen B., et al.
Publicado: (2018) -
Lyme Disease and Post-treatment Lyme Disease Syndrome: Current and Developing Treatment Options
por: Talbot, Norris C, et al.
Publicado: (2023)